Cited by 960Cancer-related Molecular PathwaysCancer, Hypoxia, and MetabolismMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.

p53 and metabolism

Vousden, Karen H., Ryan, Kevin M.·2009·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Although metabolic alterations have been observed in cancer for almost a century, only recently have the mechanisms underlying these changes been identified and the importance of metabolic transformation realized. p53 has been shown to respond to metabolic changes and to influence metabolic pathways through several mechanisms. The contributions of these activities to tumour suppression are complex and potentially rather surprising: some reflect the function of basal p53 levels that do not require overt activation and others might even promote, rather than inhibit, tumour progression.

Integrity signals

Registry

Crossref · 10.1038/nrc2715

Cites

134 of 134 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Tissue-specific Autophagy Alterations and Increased Tumorigenesis in Mice Deficient in Atg4C/Autophagin-3
Mariño, G., Salvador-Montoliu, N., Fueyo, A., Knecht, E., Mizushima, N., & López-Otı́n, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701194200 · Cited by 427
Retracted
On the origin of cancer cells
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Development by Self-Digestion
Levine, B., & Klionsky, D. J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00099-1 · Cited by 3,728
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Self-citation
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452
p53 in health and disease
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,351
Self-citation

Flagged first, then by citations

Show all 134 references

Sorted by citations

Items 201–300 of 960

Mitochondrial protein translocases for survival and wellbeing
Sokòl, A. M., Sztolsztener, M. E., Wasilewski, M., Heinz, E., & Chacińska, A. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.05.028 · Cited by 108
The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense
Itahana, Y., Han, R., Barbier, S., Lei, Z., Rozen, S., & Itahana, K. (2014) · Oncogene · doi:10.1038/onc.2014.119 · Cited by 102
Site-specific NMR mapping and time-resolved monitoring of serine and threonine phosphorylation in reconstituted kinase reactions and mammalian cell extracts
Theillet, F., Rose, H. M., Liokatis, S., Binolfi, A., Thongwichian, R., Stuiver, M., & Selenko, P. (2013) · Nature Protocols · doi:10.1038/nprot.2013.083 · Cited by 101
Interactions of ion transporters and channels with cancer cell metabolism and the tumour microenvironment
Andersen, A. P., Moreira, J. M. A., & Pedersen, S. F. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0098 · Cited by 105
UV-A Irradiation Activates Nrf2-Regulated Antioxidant Defense and Induces p53/Caspase3-Dependent Apoptosis in Corneal Endothelial Cells
Cai-ling, L., Vojnovic, D., Kochevar, I. E., & Jurkunas, U. V. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19097 · Cited by 101
Digging deeper through glucose metabolism and its regulators in cancer and metastasis
Ghanavat, M., Shahrouzian, M., Zayeri, Z. D., Banihashemi, S., Kazemi, S. M., & Saki, N. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118603 · Cited by 100
Classification of breast cancer precursors through exhaled breath
Shuster, G., Gallimidi, Z., Heyman‐Reiss, A., Dovgolevsky, E., Billan, S., Abdah‐Bortnyak, R., Kuten, A., Engel, A., Shiban, A., Tisch, U., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1317-x · Cited by 101
Metformin restores parkin-mediated mitophagy, suppressed by cytosolic p53
Song, Y., Lee, W., Lee, Y.-H., Kang, E., Cha, B.-S., & Lee, B.-W. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010122 · Cited by 98
Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?
Thomas, A., Kelly, G. L., & Strasser, A. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00996-z · Cited by 102
Radiation metabolomics and its potential in biodosimetry
Coy, S. L., Cheema, A. K., Tyburski, J. B., Laiakis, E. C., Collins, S. P., & Fornace, A. J. (2011) · International Journal of Radiation Biology · doi:10.3109/09553002.2011.556177 · Cited by 98
Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD
Zhang, C., Liu, J., Wu, R., Liang, Y., 林美华, Liu, J., Chan, C. S., Hu, W., & Feng, Z. (2014) · Oncotarget · doi:10.18632/oncotarget.2137 · Cited by 101
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis
Kowalik, M. A., Guzzo, G., Morandi, A., Perra, A., Menegon, S., Masgras, I., Trevisan, E., Angioni, M. M., Fornari, F., Quagliata, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8632 · Cited by 97
Central role of lactate and proton in cancer cell resistance to glucose deprivation and its clinical translation
Hu, X., Chao, M., & Wu, H. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2016.47 · Cited by 102
Ribosomal protein L11 mutation in zebrafish leads to haematopoietic and metabolic defects
Danilova, N., Sakamoto, K. M., & Lin, S. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08396.x · Cited by 99
Guarding the ‘translation apparatus’: defective ribosome biogenesis and the p53 signaling pathway
Chakraborty, A., Uechi, T., & Kenmochi, N. (2011) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.73 · Cited by 100
The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells
Donati, G., Bertoni, S., Brighenti, E., Vici, M., Treré, D., Volarević, S., Montanaro, L., & Derenzini, M. (2011) · Oncogene · doi:10.1038/onc.2011.48 · Cited by 100
TIGAR, TIGAR, burning bright
Lee, P., Vousden, K. H., & Cheung, E. C. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-1 · Cited by 99
Self-citation
The Intercellular Metabolic Interplay between Tumor and Immune Cells
Wang, T., Liu, G., & Wang, R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00358 · Cited by 96
Hitting cancers’ weak spots: vulnerabilities imposed by p53 mutation
Gurpinar, E., & Vousden, K. H. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.04.001 · Cited by 98
Self-citation
p53 Promotes Cardiac Dysfunction in Diabetic Mellitus Caused by Excessive Mitochondrial Respiration-Mediated Reactive Oxygen Species Generation and Lipid Accumulation
Nakamura, H., Matoba, S., Iwai‐Kanai, E., Kimata, M., Hoshino, A., Nakaoka, M., Katamura, M., Okawa, Y., Ariyoshi, M., Mita, Y., et al. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.961565 · Cited by 97
Imaging metabolic heterogeneity in cancer
Sengupta, D., & Pratx, G. (2016) · Molecular Cancer · doi:10.1186/s12943-015-0481-3 · Cited by 94
AMPK and the neuroendocrine regulation of appetite and energy expenditure
Stark, R., Ashley, S. E., & Andrews, Z. B. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.012 · Cited by 94
Clinical significance of T cell metabolic reprogramming in cancer
Herbel, C., Patsoukis, N., Bardhan, K., Seth, P., Weaver, J. D., & Boussiotis, V. A. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0110-9 · Cited by 99
Pros and Cons of Chaperone-Mediated Autophagy in Cancer Biology
Arias, E., & Cuervo, A. M. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.09.007 · Cited by 94
The p53 tumor suppressor protein regulates hematopoietic stem cell fate
Asai, T., Liu, Y., Bae, N., & Nimer, S. D. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22561 · Cited by 102
Grape seed procyanidin extract ameliorates lead-induced liver injury via miRNA153 and AKT/GSK-3β/Fyn-mediated Nrf2 activation
Liu, B., Jiang, H., Lu, J., Baiyun, R., Li, S., Lv, Y., Li, D., Wu, H., & Zhang, Z. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.09.025 · Cited by 90
p53 transcriptionally regulates SQLE to repress cholesterol synthesis and tumor growth
Sun, H., Li, L., Li, W., Yang, F., Zhang, Z., Liu, Z., & Du, W. (2021) · EMBO Reports · doi:10.15252/embr.202152537 · Cited by 90
The prolyl-isomerase Pin1 activates the mitochondrial death program of p53
Sorrentino, G., Mioni, M., Giorgi, C., Ruggeri, N., Pinton, P., Moll, U. M., Mantovani, F., & Sal, G. D. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.112 · Cited by 92
Mitochondrial recoupling: a novel therapeutic strategy for cancer
Baffy, G., Derdak, Z., & Robson, S. C. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.245 · Cited by 88
“…including synthesis of cytochrome oxidase 2, Tp53-induced glycolysis and apoptosis regulator, phosphoglycerate mutase and glucose transporter 1 (Vousden and Ryan, 2009), whereas UCP2 has a contrasting effect on cellular energy metabolism (Samudio et al, 472 British Journal of Cancer (2011)…”
Background
Comparative Analysis of Muscle Transcriptome between Pig Genotypes Identifies Genes and Regulatory Mechanisms Associated to Growth, Fatness and Metabolism
Ayuso, M., Fernández, A., Núñez, Y., Benítez, R., Isabel, B., Barragán, C., Fernández, A. I., Rey, A. I., Medrano, J. F. F., Cánovas, Á., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145162 · Cited by 94
Genome-wide profiling reveals stimulus-specific functions of p53 during differentiation and DNA damage of human embryonic stem cells
Akdemir, K. C., Jain, A. K., Allton, K. L., Aronow, B. J., Xu, X., Cooney, A. J., Li, W., & Barton, M. C. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt866 · Cited by 90
USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells
Padmanabhan, A., Candelaria, N., Wong, K.-K., Nikolai, B. C., Lonard, D. M., O’Malley, B. W., & Richards, J. S. (2018) · Nature Communications · doi:10.1038/s41467-018-03599-w · Cited by 88
NFκB/p53 crosstalk—a promising new therapeutic target
Schneider, G., & Krämer, O. H. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.10.003 · Cited by 87
Metabolic reprogramming of carcinoma-associated fibroblasts and its impact on metabolic heterogeneity of tumors
Wu, D., Zhuo, L., & Wang, X. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.11.003 · Cited by 88
GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation
Velletri, T., Romeo, F., Tucci, P., Peschiaroli, A., Annicchiarico‐Petruzzelli, M., Niklison-Chirou, M. V., Amelio, I., Knight, R. A., Mak, T. W., Melino, G., et al. (2013) · Cell Cycle · doi:10.4161/cc.26771 · Cited by 87
The role of p53 in glucose metabolism
Cheung, E. C., & Vousden, K. H. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.006 · Cited by 88
Self-citation
Cytometry in cell necrobiology revisited. Recent advances and new vistas
Włodkowic, D., Skommer, J., & Darżynkiewicz, Z. (2010) · Cytometry Part A · doi:10.1002/cyto.a.20889 · Cited by 86
The lncRNA MALAT1, acting through HIF-1α stabilization, enhances arsenite-induced glycolysis in human hepatic L-02 cells
Luo, F., Liu, X., Ling, M., Lu, L., Shi, L., Lü, X., Li, J., Zhang, A., & Liu, Q. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.06.004 · Cited by 86
Transcriptional Regulation of Energy Metabolism in Cancer Cells
Rodríguez‐Enríquez, S., Marín‐Hernández, Á., Gallardo‐Pérez, J. C., Pacheco-Velázquez, S. C., Belmont-Díaz, J., Robledo‐Cadena, D. X., Vargas-Navarro, J. L., de la Peña, N. A. C., Saavedra, E., & Moreno‐Sánchez, R. (2019) · Cells · doi:10.3390/cells8101225 · Cited by 88
p53 activates the PANK1/ miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins
Böhlig, L., Friedrich, M., & Engeland, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq796 · Cited by 85
Circadian redox oscillations and metabolism
Milev, N. B., & Reddy, A. B. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.05.012 · Cited by 89
Bcl-2 Modulation in p53 Signaling Pathway by Flavonoids: A Potential Strategy towards the Treatment of Cancer
Rahman, N., Khan, H. Z., Zia, A., Khan, A., Fakhri, S., Aschner, M., Gul, K., & Saso, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111315 · Cited by 86
SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker
Kolukula, V. K., Sahu, G., Wellstein, A., Rodriguez, O. C., Preet, A., Iacobazzi, V., D’Orazi, G., Albanese, C., Palmieri, F., & Avantaggiati, M. L. (2014) · Oncotarget · doi:10.18632/oncotarget.1831 · Cited by 86
The Emerging Role of p53 in Exercise Metabolism
Bartlett, J. D., Close, G. L., Drust, B., & Morton, J. P. (2013) · Sports Medicine · doi:10.1007/s40279-013-0127-9 · Cited by 91
The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs)
Haick, H., Amal, Ding, Liu, Tisch, Xu, Shi, Zhao, Chen, Sun, et al. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s32680 · Cited by 83
Pathophysiology of protein aggregation and extended phenotyping in filaminopathy
Kley, R. A., Oflazer, P., Leber, Y., Odgerel, Z., van der Ven, P. F. M., Olivé, M., Ferrer, I., Onipe, A., Mihaylov, M., Bilbao, J. M., et al. (2012) · Brain · doi:10.1093/brain/aws200 · Cited by 86
The emergence of protein complexes: quaternary structure, dynamics and allostery
Perica, T., Marsh, J. A., Sousa, F. L., Natan, E., Colwell, L. J., Ahnert, S. E., & Teichmann, S. A. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120056 · Cited by 87
The Roles of p53 in Mitochondrial Dynamics and Cancer Metabolism: The Pendulum between Survival and Death in Breast Cancer?
Moulder, D. E., Hatoum, D., Tay, E. S. E., Lin, Y., & McGowan, E. M. (2018) · Cancers · doi:10.3390/cancers10060189 · Cited by 87
Mitochondrial Metabolism in PDAC: From Better Knowledge to New Targeting Strategies
Reyes‐Castellanos, G., Masoud, R., & Carrier, A. (2020) · Biomedicines · doi:10.3390/biomedicines8080270 · Cited by 85
Acne Transcriptomics: Fundamentals of Acne Pathogenesis and Isotretinoin Treatment
Melnik, B. C. (2023) · Cells · doi:10.3390/cells12222600 · Cited by 86
Vascular senescence and aging: mechanisms, clinical implications, and therapeutic prospects
Picos, A., Seoane, N., Campos‐Toimil, M., & Viña, D. (2025) · Biogerontology · doi:10.1007/s10522-025-10256-5 · Cited by 84
A Metabolism Toolbox for CAR T Therapy
Xu, X., Gnanaprakasam, J. R., Sherman, J. W., & Wang, R. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00322 · Cited by 82
Bioinformatics analysis of the serine and glycine pathway in cancer cells
Antonov, A. V., Agostini, M., Morello, M., Minieri, M., Melino, G., & Amelio, I. (2014) · Oncotarget · doi:10.18632/oncotarget.2668 · Cited by 82
Dual Function of USP14 Deubiquitinase in Cellular Proteasomal Activity and Autophagic Flux
Kim, E., Park, S., Lee, J. H., Mun, J. Y., Choi, W. H., Yun, Y., Lee, J., Kim, J. H., Kang, M.-J., & Lee, M. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.058 · Cited by 80
Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells
Marbaniang, C., & Kma, L. (2018) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2018.19.9.2377 · Cited by 82
TRAF6 Restricts p53 Mitochondrial Translocation, Apoptosis, and Tumor Suppression
Zhang, X., Li, C., Zhang, L., Wu, C., Han, L., Jin, G., Rezaeian, A. H., Han, F., Liu, C., Xu, C. S., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.10.002 · Cited by 81
p63 regulates glutaminase 2 expression
Giacobbe, A., Bongiorno‐Borbone, L., Bernassola, F., Terrinoni, A., Markert, E. K., Levine, A. J., Fen, Z., Agostini, M., Zolla, L., Finazzi‐Agrò, A., et al. (2013) · Cell Cycle · doi:10.4161/cc.24478 · Cited by 79
Ablation of CD44 induces glycolysis-to-oxidative phosphorylation transition via modulation of the c-Src–Akt–LKB1–AMPKα pathway
Nam, K., Oh, S., & Shin, I. (2016) · Biochemical Journal · doi:10.1042/bcj20160613 · Cited by 80
Modeling Core Metabolism in Cancer Cells: Surveying the Topology Underlying the Warburg Effect
Reséndis-Antonio, O., Checa, A., & Encarnación‐Guevara, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012383 · Cited by 82
Mitochondrial quality control in AMD: does mitophagy play a pivotal role?
Hyttinen, J. M. T., Viiri, J., Kaarniranta, K., & Błasiak, J. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2843-7 · Cited by 82
Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase
Kinnaird, A. S., Dromparis, P., Saleme, B., Gurtu, V., Watson, K., Paulin, R., Zervopoulos, S. D., Stenson, T. H., Sutendra, G., Pink, D., et al. (2016) · European Urology · doi:10.1016/j.eururo.2015.09.014 · Cited by 78
Minireview: Obesity and Breast Cancer: A Tale of Inflammation and Dysregulated Metabolism
Simpson, E. R., & Brown, K. A. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1011 · Cited by 78
Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism
Chartoumpekis, D. V., Wakabayashi, N., & Kensler, T. W. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150049 · Cited by 78
Essential Roles of E3 Ubiquitin Ligases in p53 Regulation
Sane, S., & Rezvani, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020442 · Cited by 78
Tumor Suppressor Protein Pdcd4 Inhibits Translation of p53 mRNA
Wedeken, L., Singh, P., & Klempnauer, K.-H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.269456 · Cited by 75
Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancer
Dowling, C. M., Hollinshead, K. E. R., Grande, A. D., Pritchard, J. R., Zhang, H., Dillon, E., Haley, K. E., Papadopoulos, E., Mehta, A. K., Bleach, R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abc4897 · Cited by 76
Endoplasmic reticulum stress induced by 2-deoxyglucose but not glucose starvation activates AMPK through CaMKKβ leading to autophagy
Xi, H., Barredo, J. C., Merchan, J. R., & Lampidis, T. J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.02.037 · Cited by 78
Mitochondrial Liaisons of p53
Galluzzi, L., Morselli, E., Kepp, O., Vitale, I., Pinti, M., & Kroemer, G. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3504 · Cited by 83
TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade
Soussi, T. (2011) · Advances in cancer research · doi:10.1016/b978-0-12-386469-7.00005-0 · Cited by 77
Natural Agents Targeting Mitochondria in Cancer
Mani, S., Swargiary, G., & Singh, K. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21196992 · Cited by 76
5‐ D emethyltangeretin inhibits human nonsmall cell lung cancer cell growth by inducing G 2/M cell cycle arrest and apoptosis
Charoensinphon, N., Qiu, P., Dong, P., Zheng, J., Ngauv, P., Cao, Y., Li, S., Ho, C., & Xiao, H. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300136 · Cited by 72
ISG20L1 is a p53 family target gene that modulates genotoxic stress-induced autophagy
Eby, K. G., Rosenbluth, J. M., Mays, D. J., Marshall, C. B., Barton, C. E., Sinha, S., Johnson, K. N., Tang, L., & Pietenpol, J. A. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-95 · Cited by 74
The biology of lysine acetylation integrates transcriptional programming and metabolism
Patel, J. A., Pathak, R. R., & Mujtaba, S. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-12 · Cited by 76
HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer
Pudova, E. A., Kudryavtseva, A. V., Fedorova, M., Zaretsky, A. R., Shcherbo, D. S., Lukyanova, E., Popov, A., Садритдинова, А. Ф., Abramov, I. S., Kharitonov, S., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-4477-4 · Cited by 72
Silver-Promoted Desilylation Catalyzed by Ortho- and Allosteric Cucurbiturils
Lu, X., & Masson, E. (2010) · Organic Letters · doi:10.1021/ol100667z · Cited by 71
Centromere protein F (CENPF), a microtubule binding protein, modulates cancer metabolism by regulating pyruvate kinase M2 phosphorylation signaling
Shahid, M., Lee, M. Y., Piplani, H., Andres, A. M., Zhou, B., Yeon, A., Kim, M., Kim, H. L., & Kim, J. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1557496 · Cited by 71
Ginsenosides in cancer: A focus on the regulation of cell metabolism
Wang, Y., & Guan, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113756 · Cited by 70
Bridging epigenetics and metabolism
Phang, J. M., Liu, W., & Hancock, C. N. (2013) · Epigenetics · doi:10.4161/epi.24042 · Cited by 71
Regulation of tumor suppressor p53 at the RNA level
Vilborg, A., Wilhelm, M., & Wiman, K. G. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0609-2 · Cited by 74
Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches
Carvalho, T. M. A., Molfetta, D. D., Greco, M. R., Koltai, T., Alfarouk, K. O., Reshkin, S. J., & Cardone, R. A. (2021) · Cancers · doi:10.3390/cancers13236135 · Cited by 76
Inhibition of p53 DNA Binding Function by the MDM2 Protein Acidic Domain
Cross, B. L., Chen, L., Cheng, Q., Li, B., Yuan, Z.-M., & Chen, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228981 · Cited by 72
Multiple pathways are involved in palmitic acid-induced toxicity
Park, E., Lee, A. Y., Park, S. J., Kim, J. H., & Cho, M. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.01.027 · Cited by 69
Liver p53 is stabilized upon starvation and required for amino acid catabolism and gluconeogenesis
Prokesch, A., Graef, F. A., Madl, T., Kahlhofer, J., Heidenreich, S., Schumann, A., Moyschewitz, E., Pristoynik, P., Blaschitz, A., Knauer, M., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201600845r · Cited by 71
METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53‐wild‐type cells
Hou, Y., Zhang, X., Yao, H., Hou, L., Zhang, Q., Tao, E., Zhu, X., Jiang, S., Ren, Y., Hong, X., et al. (2023) · EMBO Reports · doi:10.15252/embr.202256325 · Cited by 69
Chemotherapeutic induction of mitochondrial oxidative stress activates GSK-3α/β and Bax, leading to permeability transition pore opening and tumor cell death
Chiara, F., Gambalunga, A., Sciacovelli, M., Nicolli, A., Ronconi, L., Fregona, D., Bernardi, P., Rasola, A., & Trevisan, A. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.184 · Cited by 69
TP53 mutation hits energy metabolism and increases glycolysis in breast cancer
Papp, H., Pongor, L. S., Munkácsy, G., Horváth, G., Nagy, Á. M., Ambrus, A., Hauser, P., Szabó, A., Tretter, L., & Győrffy, B. (2016) · Oncotarget · doi:10.18632/oncotarget.11594 · Cited by 72
p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53
Zhou, Y., Niu, W., Luo, Y., Li, H., Xie, Y., Wang, H., Liu, Y., Fan, S., Li, Z., Xiong, W., et al. (2019) · Cancer Science · doi:10.1111/cas.13928 · Cited by 66
Regulation of p53 by Mdm2 E3 Ligase Function Is Dispensable in Embryogenesis and Development, but Essential in Response to DNA Damage
Tollini, L. A., Jin, A., Park, J., & Zhang, Y. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.06.006 · Cited by 66
Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
Liu, Y.-H., Hu, C., Hsu, Y.-S., & Lee, W. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05259-w · Cited by 74
Mitochondrial p53 mediates a transcription-independent regulation of cell respiration and interacts with the mitochondrial F₁F₀-ATP synthase
Bergeaud, M., Mathieu, L., Guillaume, A., Moll, U. M., Mignotte, B., Floch, N. L., Vayssière, J., & Rincheval, V. (2013) · Cell Cycle · doi:10.4161/cc.25870 · Cited by 74
Carbon Source Metabolism and Its Regulation in Cancer Cells
Yin, C., Qie, S., & Sang, N. (2012) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v22.i1.20 · Cited by 67
IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesis
Asano, Y., Kawase, T., Okabe, A., Tsutsumi, S., Ichikawa, H., Tatebe, S., Kitabayashi, I., Tashiro, F., Namiki, H., Kondo, T., et al. (2016) · Scientific Reports · doi:10.1038/srep19174 · Cited by 67
The p53/microRNA Network in Cancer: Experimental and Bioinformatics Approaches
Hünten, S., Siemens, H., Kaller, M., & Hermeking, H. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-5590-1_5 · Cited by 66
p53-inducible DPYSL4 associates with mitochondrial supercomplexes and regulates energy metabolism in adipocytes and cancer cells
Nagano, H., Hashimoto, N., Nakayama, A., Suzuki, S., Miyabayashi, Y., Yamato, A., Higuchi, S., Fujimoto, M., Sakuma, I., Beppu, M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804243115 · Cited by 66
The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets
Burns, J. E., Hurst, C. D., Knowles, M. A., Phillips, R. M., & Allison, S. J. (2021) · Cancer Science · doi:10.1111/cas.15047 · Cited by 66
Small molecule compounds targeting the p53 pathway: are we finally making progress?
Yu, X., Narayanan, S., Vázquez, A., & Carpizo, D. R. (2014) · APOPTOSIS · doi:10.1007/s10495-014-0990-3 · Cited by 68
Loss of DJ-1 impairs antioxidant response by altered glutamine and serine metabolism
Meiser, J., Delcambre, S., Wegner, A., Jäger, C., Ghelfi, J., d’Hérouël, A. F., Dong, X., Weindl, D., Stautner, C., Nonnenmacher, Y., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.019 · Cited by 66
Role of Human Monocarboxylate Transporter 1 (hMCT1) and 4 (hMCT4) in Tumor Cells and the Tumor Microenvironment
Liu, T., Han, S., Yao, Y., & Zhang, G. (2023) · Cancer Management and Research · doi:10.2147/cmar.s421771 · Cited by 65
Energy Management by Enhanced Glycolysis in G1-phase in Human Colon Cancer Cells In Vitro and In Vivo
Bao, Y., Mukai, K., Hishiki, T., Kubo, A., Ohmura, M., Sugiura, Y., Matsuura, T., Nagahata, Y., Hayakawa, N., Yamamoto, T., et al. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0669-t · Cited by 64
Hypoxia downregulates p53 but induces apoptosis and enhances expression of BAD in cultures of human syncytiotrophoblasts
Chen, B., Longtine, M. S., Sadovsky, Y., & Nelson, D. M. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00154.2010 · Cited by 66

Authors: Vousden, K. H., & Ryan, K. M.
Affiliations: Cancer Research UK Scotland Institute (GB)
ORCID: Vousden, Karen H.
Ryan, Kevin M.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2009-09-17
Volume: 9
Issue: 10
Pages: 691-700
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc2715
OpenAlex: W1991510903
Cited by: 959
References: 134
Citations by year: 2026: 23 · 2025: 39 · 2024: 37 · 2023: 36 · 2022: 49 · 2021: 46 · 2020: 44 · 2019: 39 · 2018: 49 · 2017: 52 · 2016: 60 · 2015: 78 · 2014: 84 · 2013: 97 · 2012: 82
FWCI: 6.60
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Funders: Cancer Research UK
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: p53, cancer metabolism, tumor suppression, tumor progression, metabolic pathways, cancer cells
MeSH terms: Autophagy, Cell Transformation, Neoplastic, Glycolysis, Humans, Neoplasms, Tumor Suppressor Protein p53, Oxidative Stress, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

p53 and metabolism

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks